Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia

Stopped Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents

Conditions

• Hypercholesterolemia

Interventions

• DRUG: Lapaquistat acetate and stable statin therapy
• DRUG: Stable statin therapy

Sponsor

Takeda